Institute for International Research

Niall Barron, Ph.D., Dublin City University, Ireland

Allison Bianchi, Ph.D., Amgen Inc.

Kara Calhoun, Ph.D., Genentech, Inc.

Gang Chen, Ph.D., Regeneron Pharmaceuticals, Inc.

Gisela Chiang, Ph.D., Biogen Idec

John H. Chon, Ph.D., Percivia, LLC

Valentina C. Ciccarone, Ph.D., MacroGenics, Inc.

Matthew S. Croughan, Ph.D., Keck Institute

Lekan Daramola, Ph.D., MedImmune Ltd, United Kingdom

John Delaney, Ph.D., Amgen Inc.

Lynn Dickey, Ph.D., Biolex Therapeutics

Alan Dickson, Ph.D., The University of Manchester, United Kingdom

Jana Dolnikova, M.S., Biogen Idec

Haimanti Dorai, Ph.D., Centocor

Chris Dowd, Ph.D., Genentech, Inc.

Tim Edmunds, Ph.D., Genzyme Corporation

James Fandl, Ph.D., Regeneron Pharmaceuticals, Inc.

Brian D. Follstad, Ph.D., Amgen Inc.

Michael W. Glacken, Ph.D., Millennium Pharmaceuticals

Chetan Goudar, Ph.D., Bayer HealthCare

Timothy Gryseels, M.A., Pfizer

Adrian Haines, Ph.D., Lonza Biologics, United Kingdom

Pam Hawley-Nelson, Ph.D., MedImmune

David C. James, Ph.D., University of Sheffield, United Kingdom

John Joly, Ph.D., Genentech, Inc.

Kevin Kayser, Ph.D., SAFC

Delfi Krishna, Ph.D., GlaxoSmithKline

Michael Laird, Ph.D., Genentech, Inc.

Kevin M. McCarthy, Ph.D., Pfizer Biotherapeutics

Majid Mehtali, Ph.D., Vivalis, France

Michael Milburn, Ph.D., Metabolon

Andy Racher, Ph.D., Lonza Biologics, United Kingdom

Tiffany D. Rau, Ph.D., GlaxoSmithKline

Stephanie E. Rieder, Ph.D., Abbott Bioresearch Center

Anthony (Tony) Rossomando, Ph.D., Alnylam Biotherapeutics

Laura Simmons, Ph.D., Genentech, Inc.

Andrew Snowden, Ph.D., Biogen Idec

Hartmut Tintrup, Ph.D., Cevec Pharmaceuticals GmbH, Germany

Athena Wong, Ph.D., Genentech, Inc.

Helena Y. Makagiansar, Ph.D., Biogen Idec